U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived - Serotonin-norepinephrine reuptake inhibitors - Document - PDFSEARCH.IO

First Page	Meta Content
	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Open Document File Size: 2,22 MB Share Result on Facebook Company CV Risk Group / Cardiovascular Risk Group / ITT / / Country United States / New Zealand / / MedicalCondition Metabolic Syndrome / Diabetes Mellitus / Cardiovascular Diseases / Obesity / / Organization U.S. Food and Drug Administration / Endocrinologic and Metabolic Drugs Advisory Committee / / Person Vital Sign / / Position General / Executive / / Product Meridia / Antihypertensive Medication / / ProvinceOrState Illinois / / Technology 165 Appendix C. Algorithm / / SocialTag Anorectics Phenethylamines Sibutramine Medicine Chemistry Management of obesity Obesity Health Organochlorides Serotonin-norepinephrine reuptake inhibitors

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archivedAdd to Reading List